Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
  1. 4 Grant or award Director acquired 1,500 shares (grant or award)
  2. 4 Grant or award Director acquired 1,500 shares (grant or award)
  3. 4 Grant or award Director acquired 1,500 shares (grant or award)
  4. 4 Grant or award Director acquired 1,500 shares (grant or award)
  5. 4 Grant or award Secretary & VP Finance & Admin acquired 4,500 shares (grant or award)
  6. 4 Grant or award President & CEO acquired 11,000 shares (grant or award)
  7. 4 Shares withheld for taxes Secretary & VP Finance & Admin gave up 657 shares (to pay taxes)
  8. 4 Open-market buy Interim Executive Chairman bought 2,000 shares at $0.39 ($780)
  9. 4 Open-market buy Interim Executive Chairman bought 2,000 shares at $0.39 ($780)
  10. 4 Open-market buy Interim Executive Chairman bought 2,000 shares at $0.43 ($860)
  11. 4 Open-market buy Director bought 5,000 shares at $0.41 ($2,041)
  12. 4 Open-market buy Interim Executive Chairman bought 2,715 shares at an average $0.42 ($1,136)
  13. 4 Open-market buy Director bought 2,000 shares at $0.41 ($820)
  14. 4 Open-market buy Interim Executive Chairman bought 1 shares at $1,750.00 ($1,750)
  15. 4 Grant or award Director acquired 40,000 shares (grant or award)
  16. 4 Grant or award Director acquired 20,000 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Shares withheld for taxes Secretary & VP Finance & Admin gave up 4,011 shares (to pay taxes)
  19. 4 Shares withheld for taxes President & CEO gave up 8,954 shares (to pay taxes)
  20. 4 Grant or award Director acquired 10,000 shares (grant or award)

Page 4 of 15 · 281 filings